These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32839811)

  • 21. First-generation Antipsychotics Are Often Prescribed in the Emergency Department but Are Often Not Administered with Adjunctive Medications.
    Campillo A; Castillo E; Vilke GM; Hopper A; Ryan V; Wilson MP
    J Emerg Med; 2015 Dec; 49(6):901-6. PubMed ID: 26433424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Droperidol for acute migraine headache.
    Richman PB; Reischel U; Ostrow A; Irving C; Ritter A; Allegra J; Eskin B; Szucs P; Nashed AH
    Am J Emerg Med; 1999 Jul; 17(4):398-400. PubMed ID: 10452443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of the FDA warning on the use of droperidol by u.s. Emergency physicians.
    Richards JR; Weiss SJ; Bretz SW; Schneir AB; Rinetti D; Derlet RW
    Cal J Emerg Med; 2003 Jan; 4(1):3-9. PubMed ID: 20852711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inside the black box: current policies and concerns with the United States Food and Drug Administration's highest drug safety warning system.
    Halloran K; Barash PG
    Curr Opin Anaesthesiol; 2010 Jun; 23(3):423-7. PubMed ID: 20446348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescribing preferences in rapid tranquillisation: a survey in Belgian psychiatrists and emergency physicians.
    Bervoets C; Roelant E; De Fruyt J; Demunter H; Dekeyser B; Vandenbussche L; Titeca K; Pieters G; Sabbe B; Morrens M
    BMC Res Notes; 2015 Jun; 8():218. PubMed ID: 26043843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence-based review of the black-box warning for droperidol.
    Jackson CW; Sheehan AH; Reddan JG
    Am J Health Syst Pharm; 2007 Jun; 64(11):1174-86. PubMed ID: 17519460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective real-time evaluation of the QTc interval variation after low-dose droperidol among emergency department patients.
    Hernández-Rodríguez L; Bellolio F; Cabrera D; Mattson AE; VanMeter D; Grush AE; Oliveira J E Silva L
    Am J Emerg Med; 2022 Feb; 52():212-219. PubMed ID: 34959024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDA advisory panel discusses droperidol concerns.
    Young D
    Am J Health Syst Pharm; 2004 Feb; 61(3):219-20, 222. PubMed ID: 14986550
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence-based review and appraisal of the use of droperidol in the emergency department.
    Lai PC; Huang YT
    Ci Ji Yi Xue Za Zhi; 2018; 30(1):1-4. PubMed ID: 29643708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review of the effectiveness and safety of droperidol for pediatric agitation in acute care settings.
    Ramsden SC; Pergjika A; Janssen AC; Mudahar S; Fawcett A; Walkup JT; Hoffmann JA
    Acad Emerg Med; 2022 Dec; 29(12):1466-1474. PubMed ID: 35490341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Droperidol use in the emergency department is not safe.
    Prosser RL
    Acad Emerg Med; 2006 May; 13(5):585-6; author reply 586-7. PubMed ID: 16641482
    [No Abstract]   [Full Text] [Related]  

  • 32. Parenteral sedation of elderly patients with acute behavioral disturbance in the ED.
    Calver L; Isbister GK
    Am J Emerg Med; 2013 Jun; 31(6):970-3. PubMed ID: 23685060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Droperidol analgesia for opioid-tolerant patients.
    Richards JR; Richards IN; Ozery G; Derlet RW
    J Emerg Med; 2011 Oct; 41(4):389-96. PubMed ID: 20832967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective evaluation of ketamine versus droperidol on time to restraint removal in agitated emergency department patients.
    Krenz JR; Medeiros K; Lupez K
    Am J Emerg Med; 2023 Jul; 69():23-27. PubMed ID: 37031618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parenteral Antipsychotic Choice and Its Association With Emergency Department Length of Stay for Acute Agitation Secondary to Alcohol Intoxication.
    Cole JB; Klein LR; Martel ML
    Acad Emerg Med; 2019 Jan; 26(1):79-84. PubMed ID: 29851193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reviewing case reports and the droperidol warning: FDA response.
    Chang N; Simone A; Schultheis L; Rappaport B
    Anesth Analg; 2003 Nov; 97(5):1542. PubMed ID: 14570686
    [No Abstract]   [Full Text] [Related]  

  • 37. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron.
    Charbit B; Albaladejo P; Funck-Brentano C; Legrand M; Samain E; Marty J
    Anesthesiology; 2005 Jun; 102(6):1094-100. PubMed ID: 15915019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of low-dose droperidol on the QT interval during and after general anesthesia: a placebo-controlled study.
    White PF; Song D; Abrao J; Klein KW; Navarette B
    Anesthesiology; 2005 Jun; 102(6):1101-5. PubMed ID: 15915020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview of intravenous amisulpride as a new therapeutic option for the prophylaxis and treatment of postoperative nausea and vomiting.
    Smyla N; Koch T; Eberhart LH; Gehling M
    Expert Opin Pharmacother; 2020 Apr; 21(5):517-522. PubMed ID: 31971450
    [No Abstract]   [Full Text] [Related]  

  • 40. Droperidol: efficacy and side effects in psychiatric emergencies.
    Chambers RA; Druss BG
    J Clin Psychiatry; 1999 Oct; 60(10):664-7. PubMed ID: 10549682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.